CBTRUS provides up-to-date statistics on primary malignant & non-malignant brain and other CNS tumors in the US. Reports are published in Neuro-Oncology.
In 2018, a total of 379,695 years of expected life were lost due to early death attributed to brain and other CNS tumors. The majority of these deaths (96%) were due to malignant tumors.
For more statistics, please see: https://t.co/AV84w77Z4V
@NeuroOnc
There was a slight statistically significant decrease in incidence of malignant primary brain tumors from 2004-2017. Non-malignant brain tumors had statistically significant increases in incidence from 2004-2018, followed by a non-significant decrease from 2018-2022.
@NeuroOnc
In ages 0-14 years malignant brain and other CNS cancer is the most common cause of cancer death, second among ages 15-39 years, and the twelfth among older adults ages 40+ years.
For more statistics see our other statistical reports: https://t.co/AV84w78wUt
@NeuroOnc
#BrainTumors were the most common newly diagnosed #childhoodcancer in ages 0-14 years and the second most common in adolescents and young adults ages 15-39 years.
For more statistics on brain and other #CNStumors, please see https://t.co/AV84w77Z4V
@NeuroOnc
We are excited to announce the free-to-view publication of the 28th annual CBTRUS Statistical Report focused on all primary brain and other CNS tumors diagnosed in the United States in partnership with @QuinnOstrom.
https://t.co/AV84w77Z4V
@NeuroOnc
Since 2004, incidence of brain tumors was consistently higher than any other tumor type in ages 0-19. For brain tumors, incidence increased significantly from 2004 to 2016, followed by significant decrease after 2016. #ChildhoodCancerAwareness@PBTF@NeuroOnc
In honor of #ChildhoodCancerAwareness month, we are excited to announce publication of the CBTRUS special Statistical Report focused on brain and other CNS tumors in children and adolescents. https://t.co/AV84w78wUt
@PBTF@prtbtcatduke
In the United States, glioblastoma has an average annual age-adjusted incidence rate of 3.27 per 100,000 people, translating to roughly 10,900 new cases diagnosed each year.
#Glioblastoma
Yesterday was #Glioblastoma Awareness Day. #GBM is the most commonly diagnosed malignant brain tumor.
Download and share a summary of fast facts here: https://t.co/0yxUW6w6mu
May 17 was Diffuse Intrinsic Pontine Glioma (DIPG) awareness day. This is a rare and lethal childhood cancer. Starting 2024, the pons site was made identifiable by US cancer registries allowing us to calculate incidence of DIPG.
It's time to #DefeatDIPG. #GoGoldandGrayEveryDay
#GrayMay is an opportunity for the brain tumor community to propel research and treatments forward. #GoGrayinMay to help make real, tangible progress in the fight to conquer and cure brain tumors: https://t.co/aWYPYSBSQx
#BTAM@NeuroOnc
Without them, there would be no us. Thank you to all the cancer registrars who make our work possible. Happy National Cancer Registrars week!
@NeuroOnc#ncrw25
#ActionDays2025 starts today!
Advocates from around the country meet at Capital Hill to promote important childhood cancer issues. Learn more about how to get involved: https://t.co/jksgRJM9NT
@NeuroOnc#childhoodcancer#Cancer#advocacy
It's International Childhood Cancer Day!
In the US, brain tumors are the most common cancer type and the leading cause of cancer death among those aged 0-14. (CBTRUS Statistical Report, 2024).
@NeuroOnc#throughtheirhands#ICCD2023#CUREALL#TREEOFLIFE
CBTRUS is the premier brain tumor registry through which we are able to promote continued research. On #WorldCancerDay we acknowledge all the cancer registrars who work tirelessly and the communities they serve.
Thanks to @NCRAnews and @NAACCR for their advocacy efforts. The bill now heads to the House of Representatives. It would be a major milestone for #CancerResearch and our #Veterans!
Great news for our #data: the Counting Veterans' Cancer Act of 2023 was passed this week.
This act allows the VA to report #cancer cases without need for data use agreements, improve the completeness of cancer statistics for states and the nation, and supports research. @NAACCR
#GrayMay is a time to unite with people living with #braintumors & their loved ones to spread awareness about this deadly disease.
Share quick, impactful stats about where we are in our mission to conquer & cure brain tumors, and inspire others to take action this month. #BTAM